On February 11, Robert Darwin will participate on a panel.
Innovation: Unlocking Opportunities in the Animal Health Sector
This dynamic panel will explore key trends driving innovation and what investors look for when evaluating potential opportunities. Gain valuable perspectives on how startups and established players can attract funding and thrive in a rapidly evolving market.
- Moderated by Robert Darwin, Partner, Sidley
- Julia Stephanus, Partner, Borealis Ventures (Venture Capital)
- Jolian Howell, Chief Commercial Officer, Carus Animal Health (Angel)
- Marcus Remmers, Partner, Novo Holdings A/S
On February 12, Chris Boyle will moderate two panels.
Sustaining Resilience and Driving Future Growth: The Analysts’ Perspective
Future-proof your business by hearing how issues such as the growth of the veterinary services industry, innovations in age-related and chronic condition care, and the response to urgent dermatology and oncology needs will impact the industry.
- Moderated by Chris Boyle, Partner, Sidley
- Brandon Vasquez, Research Analyst, Healthcare, William Blair
- Dave Westenberg, Managing Director Equity Research, Piper Sandler
- Navann Ty, Lead Analyst for Healthcare, BNP Paribas
Impact of Generics on the Wider Animal Health Industry
Whilst health insurance drives adoption of generics in the human health market, animal health lags behind with vets often dispensing the pioneer product over a generic equivalent. Is there an incentive for vets to prescribe generics? Is there a moral obligation to offer lower priced drugs to clients? We look at the potential for generics to increase efficiencies globally, whilst considering the vet perspective.
- Moderated by Chris Boyle, Partner, Sidley
- Angelo Gatto, CEO, Chanelle Pharma
- Kimberly Simmons, Director, Global Regulatory Affairs, Clinglobal
- Xavier Molins, Head of Regulatory Affairs EU, Bimeda Ireland & Chair of the Board of Directors, Access VetMed
